Darlene M Deptula-Hicks's Net Worth

$728 Thousand

Estimate Recalculated Jan 6, 2025 04:59PM EST

Who is Darlene M Deptula-Hicks?

Darlene M Deptula-Hicks does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PIERIS PHARMACEUTICALS, INC., F-star Therapeutics, Inc., Xenetic Biosciences, Inc., ICAD INC, T2 Biosystems, Inc., TECHNEST HOLDINGS INC, and IMCOR PHARMACEUTICAL CO.

SEC CIK

Darlene M Deptula-Hicks's CIK is 0001089409

Past Insider Trading and Trends

2016 was Darlene M Deptula-Hicks's most active year for acquiring shares with 10 total transactions. Darlene M Deptula-Hicks's most active month to acquire stocks was the month of November. 2010 was Darlene M Deptula-Hicks's most active year for disposing of shares, totalling 6 transactions. Darlene M Deptula-Hicks's most active month to dispose stocks was the month of February. 2017 saw Darlene M Deptula-Hicks paying a total of $14,320.00 for 4,000 shares, this is the most they've acquired in one year. In 2023 Darlene M Deptula-Hicks cashed out on 195,482 shares for a total of $401,831.44, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $15

SVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5K
$1.66
$8,300.00
5K
Jun 13
Form 4
—
0
—
—
0
Sep 1
Form 3
—
0
—
—
0
No matching records found

F-star Therapeutics, Inc. No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-56.44K
$7.12
-$401,831.44
0
Mar 8
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Jan 9
Form 4/A
∞
26.44K
—
—
26.44K
Nov 20
Form 4
—
0
—
—
0
Mar 9
Form 4
+113.48%
30K
—
—
56.44K
Feb 1
Form 4
—
0
—
—
0
Nov 20
Form 3
—
0
—
—
0
No matching records found

Xenetic Biosciences, Inc. (XBIO) Snapshot price: $4.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4/A
—
0
—
—
0
Dec 20
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Dec 20
Form 3
—
0
—
—
0
No matching records found

ICAD INC (ICAD) Snapshot price: $1.48

Exec VP Finance, CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 29
Form 4
-3.92%
-5.11K
$1.24
-$6,333.92
125.06K
Mar 3
Form 4
-3.28%
-4.41K
$2.00
-$8,816.00
130.16K
Jul 19
Form 4
-4.68%
-6.61K
$1.43
-$9,456.59
134.57K
Jun 1
Form 4
-15.04%
-25.00K
$1.40
-$35,003.01
141.18K
Mar 9 - Mar 11
Form 4
+43.04%
50K
—
—
166.18K
Mar 1
Form 4
-3.66%
-4.41K
$1.18
-$5,201.44
116.18K
Jul 18
Form 4
-3.53%
-4.41K
$2.84
-$12,518.72
120.59K
Jul 18
Form 4
+150.00%
75K
—
—
125K
Jun 25
Form 4
∞
50K
—
—
50K
Jul 18
Form 3
—
0
—
—
0
No matching records found

T2 Biosystems, Inc. (TTOO) Snapshot price: $2.94

SVP & Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
4K
$3.58
$14,320.00
4K
Jun 6
Form 4
—
0
—
—
0
May 1
Form 3
—
0
—
—
0
No matching records found